 Fluvoxamine
"Fluvoxamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin reuptake inhibitor. It is effective in the treatment of depression, obsessive-compulsive disorders, anxiety, panic disorders, and alcohol amnestic disorders.
| Descriptor ID |
D016666
|
| MeSH Number(s) |
D02.092.570.665.250
|
| Concept/Terms |
Fluvoxadura- Fluvoxadura
- Merck dura Brand of Fluvoxamine Maleate
Fluvoxamin-ratiopharm- Fluvoxamin-ratiopharm
- Fluvoxamin ratiopharm
- Ratiopharm Brand of Fluvoxamine Maleate
- ratio-Fluvoxamine
- ratio Fluvoxamine
Luvox- Luvox
- Solvay Brand of Fluvoxamine Maleate
- Fevarin
- Floxyfral
- Dumirox
- Faverin
Novo-Fluvoxamine- Novo-Fluvoxamine
- Novo Fluvoxamine
- Novopharm Brand of Fluvoxamine Maleate
Nu-Fluvoxamine- Nu-Fluvoxamine
- Nu Fluvoxamine
- Nu-Pharm Brand of Fluvoxamine Maleate
- Nu Pharm Brand of Fluvoxamine Maleate
PMS-Fluvoxamine- PMS-Fluvoxamine
- PMS Fluvoxamine
- Pharmascience Brand of Fluvoxamine Maleate
Desiflu- Desiflu
- Declimed Brand of Fluvoxamine Maleate
|
Below are MeSH descriptors whose meaning is more general than "Fluvoxamine".
Below are MeSH descriptors whose meaning is more specific than "Fluvoxamine".
This graph shows the total number of publications written about "Fluvoxamine" by people in this website by year, and whether "Fluvoxamine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fluvoxamine" by people in Profiles.
-
Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA. Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610.
-
Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E. Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud. 2005; 21(4):431-43.
-
Ram?rez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, Ratain MJ. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. Drug Metab Dispos. 2004 Sep; 32(9):930-6.
-
Hudson JI, McElroy SL, Raymond NC, Crow S, Keck PE, Carter WP, Mitchell JE, Strakowski SM, Pope HG, Coleman BS, Jonas JM. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry. 1998 Dec; 155(12):1756-62.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|